Tactile Systems (TCMD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
10 Mar, 2026Executive summary
Annual Meeting scheduled for May 6, 2026, to elect nine directors, ratify the auditor, approve executive compensation, and amend the Certificate of Incorporation regarding director removal.
Proxy materials are available online, with options for electronic or paper delivery to shareholders.
Board recommends voting FOR all proposals.
Voting matters and shareholder proposals
Proposals include: election of nine directors, ratification of Grant Thornton LLP as auditor for 2026, advisory approval of 2025 executive compensation, and amendment to allow director removal consistent with Delaware law.
Board recommends FOR all proposals.
Shareholders may submit proposals for the 2027 meeting by November 25, 2026.
Board of directors and corporate governance
Board consists of nine nominees, eight of whom are independent; all committees are fully independent.
Board leadership is separated between CEO and Chairman.
Annual election of all directors; no supermajority voting or poison pill.
Board and committees conduct annual evaluations, and stockholders can communicate directly with the Board.
Board diversity includes gender and racial/ethnic representation.
Latest events from Tactile Systems
- Double-digit revenue and margin growth in 2025, with 2026 guidance for continued expansion.TCMD
Q4 202517 Feb 2026 - Q2 revenue up 7%, net income $4.3M, guidance trimmed, margins and innovation strong.TCMD
Q2 20242 Feb 2026 - Strong growth, new products, and tech investments position for accelerated expansion in 2025.TCMD
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 revenue up 5%, gross margin expands, net income down, $30M buyback program authorized.TCMD
Q3 202417 Jan 2026 - New product launches and policy shifts position the business for growth and operational efficiency in 2025.TCMD
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Strong growth and innovation position the business to lead in a $10B underpenetrated market.TCMD
Oppenheimer 35th Annual Health Care MedTech and Services Conference26 Dec 2025 - Strategic execution and innovation drive double-digit growth and market leadership in core segments.TCMD
Piper Sandler 37th Annual Healthcare Conference2 Dec 2025 - Q4 revenue up 10.2%, improved margins, and 2025 guidance targets 8–10% growth.TCMD
Q4 20242 Dec 2025 - Annual meeting covers director elections, compensation, new equity plan, and ESG oversight.TCMD
Proxy Filing1 Dec 2025